CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 4, May 2012
AFRICA
221
7.
Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M.
Dose-dependent fetal complications of warfarin in pregnant women
with mechanical heart valves.
J Am Coll Cardiol
1999;
33
: 1637–1641.
8.
Pieper PG, Balci AP, Van Dijk AP. Pregnancy in women with prosthetic
valves
. Neth Heart J
2008;
16
: 406–411.
9.
Criteria Committee of the New York Association.
Nomenclature and
Criteria for Diagnosis of Disease of the Heart and Great Vessels
, 6th
edn. Boston: Brown, 1964.
10. Hameed A, Karaalp IS Tummala PP,
et al
. The effect of valvular heart
disease on maternal and fetal outcome of pregnancy.
J Am Coll Cardiol
2001;
37
: 893–899.
11. McLintock C, McCowan LME, North RA. Maternal complications
and pregnancy outcomes in women with mechanical prosthetic valves
treated with enoxaprin.
Br J Obstet Gynecol
2009;
16
: 1585–1592.
12. Quinn J, Von Kiemperer K, Brooks R, Peebles D, Walker F, Cohen H.
Use of high intensity adjusted dose low molecular weight heparin in
women with mechanical heart valves during pregnancy: a single centre
experience.
Haematologica
2009;
94
(11): 1608–1612.
13. Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in preg-
nant women with rheumatic mitral stenosis.
Am J Cardiol
2003;
91
:
1382–1385.
14. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women
with mechanical heart valves: a systemic review of the literature.
Arch
Intern Med
2000;
160
: 191–196.
15. Caceres-Loriga FM. Prosthetic valve thrombosis: is it time for a new
consensus conference?
Euro J Echocardiogr
2008;
9
:
413–414.
16. Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic
heart valves (Review).
Mt Sinai J Med
2004;
71
: 322–329.
17. Kulik A, Rubens FD, Wells PS, Kearon C, Mesana TG, van Berkom
J, Lam BK. Early postoperative anticoagulation after mechanical
valve replacement: a systemic review.
Ann Thorac Surg
2006;
81
(2):
770–781.
18. Warnes CA. Prosthetic heart valves. In: Steer PJ, Gatzoulis MA, Baker
P, eds.
Heart Disease in Pregnancy
. London: RCOG, 2006: 157–168.
19. Maxwell C, Sermer M. Mechanical heart valves and pregnancy.
Fetal
Matern Med Rev
2007;
18
(4): 311–331.
20. Elkayam U, Bitar F. Valvular heart disease and pregnancy part 11; pros-
thetic valves (Review).
J Am Coll Cardiol
2005;
46
: 403–410.
21. Khamooshi AJ, Kashfi F, Hoseini S, Tababaei MB, Javadpour H, Noohi
F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an
answer?
Asian Cardiovasc Thorac Ann
2007;
15
(6): 493–496.
22. Maxwell C, Poppas A, Dunn E, Sermer M. Pregnancy, mechanical heart
valves and anticoagulation navigating the complexities of management
during gestation. In: Rosene-Montella K, Keeley EJ, Barbour LA, Lee
RV, eds.
Medical Care of Pregnant Patient
. 2nd edn. Philadelphia:
American College of Physicians, 2007: 344–355.
23. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy.
Circulation
2003;
107
: 1240–1246.
24. Cotrufo M, De Feo F, De Santos LS,
et al.
Risk of warfarin during
pregnancy with mechanical heart valves.
Obstet Gynecol
2002;
99
(1):
35–40.
25. North RA, Sadler I, Stewart AW, McCowan LM, Kerr AR. White HD.
Long term survival and valve-related complications in young women
with cardiac valve replacement.
Circulation
1999;
99
: 2669–2676.
26. Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M.
Anticoagulation in patients with mechanical valves during pregnancy.
Asian Cardiovasc Thorac Ann
2005;
13
: 30–33.
27. Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J. Pregnancy
and mechanical heart valves replacement: dilemma of anticoagulation.
Euro J Cardiothorac Surg
2002;
22
: 223–227.
28. Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the
prophylaxis of thromboembolism in women with prosthetic mechanical
heart valves during pregnancy.
Thromb Haemost
2004;
92
: 747–751.
29. James AH, Brancazio LR, Gehring TR, Wang A, Ortel TL. Low
molecular weight heparin for thrombo-prophylaxis in pregnant women
with mechanical heart valves.
J Matern Fetal Neonatal Med
2006;
19
:
543–549.
30. Chitsike RS, Jacobsen BF, Manga P, Rhemtula HA, Moodley S, Toweel
GD. A prospective trial showing the safety of adjusted dose enoxaparin
for thromboprophylaxsis of pregnant women with mechanical pros-
thetic heart valved.
Clin Appl Thromb Hemost
2010, June13. (Epub
ahead of print).
31. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant
women with prosthetic heart valves.
J Cardiovasc Pharmacol Ther
2004;
9
:
107–115.
32. Rahaman J, Rahman MS, Al-Suleiman SA, Al-Jama FE. Pregnancy
complicated by maternal cardiac disease: a review of 274 patients.
Obstet Gynecol
2000;
20
(3): 243–245.
33. Sahwney H, Aggarwal N, Vasishta K, Sharma Y, Grover A. Maternal
and perinatal outcome in rheumatic heart disease.
Int J Gynaecol Obstet
2003:
81
(2): 153–156.
34. Sahnoun-Trabelsi I, Jimenez M, Choussat A, Roudaut R. Prosthetic
valve thrombosis in pregnancy. A single-center study of 12 cases.
Arch
Mal Coeur Vaiss
2004;
97
:
305–331.
35. Bonow RO, Carabello BA, Chatterjee K, de Leon A Jr, Faxon DP,
Freed MD,
et al
. ACC/AHA 2006 guidelines for the management
of patients with valvular heart disease: a report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines (writing Committee to revise the 1998 guidelines
for the management of patients with valvular heart disease) devel-
oped in collaboration with the Society of Cardiovascular anesthesi-
ologists endorsed by the Society for Cardiovascular Angiography and
Interventions and the Society of Thoracic Surgeons.
J Am Col Cardiol
2006;
48
: c1–148.
HEALTHCARE
